Next Article in Journal
Targeted Therapy in HR+ HER2− Metastatic Breast Cancer: Current Clinical Trials and Their Implications for CDK4/6 Inhibitor Therapy and beyond Treatment Options
Next Article in Special Issue
Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment
Previous Article in Journal
Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer
Previous Article in Special Issue
Microtubule-Based Mitochondrial Dynamics as a Valuable Therapeutic Target in Cancer
 
 
Article

Article Versions Notes

Cancers 2021, 13(23), 5995; https://doi.org/10.3390/cancers13235995
Action Date Notes Link
article xml file uploaded 29 November 2021 09:34 CET Original file -
article xml uploaded. 29 November 2021 09:34 CET Update -
article pdf uploaded. 29 November 2021 09:34 CET Version of Record -
article supplementary file uploaded. 29 November 2021 09:34 CET - https://www.mdpi.com/2072-6694/13/23/5995#supplementary
article html file updated 29 November 2021 09:36 CET Original file -
article xml file uploaded 29 November 2021 09:57 CET Update -
article xml uploaded. 29 November 2021 09:57 CET Update https://www.mdpi.com/2072-6694/13/23/5995/xml
article pdf uploaded. 29 November 2021 09:57 CET Updated version of record https://www.mdpi.com/2072-6694/13/23/5995/pdf
article html file updated 29 November 2021 10:01 CET Update -
article html file updated 30 July 2022 19:23 CEST Update https://www.mdpi.com/2072-6694/13/23/5995/html
Back to TopTop